Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
Superinvestors holding SANA, Q2 2026
No superinvestor reported holding SANA in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SANA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2024
0 superinvestors holding at quarter end
- Sold out
- Duquesne Family Office
Q1 2024
1 superinvestor holding at quarter end